)
Visual21 Nov 2025
Data center suppliers
bioMérieux (BIM) investor relations material
bioMérieux Q3 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 TU earnings summary4 Nov, 2025
Executive summary
Q3 2025 organic sales grew 3%, reaching nearly EUR 950 million, with 7.6% growth excluding China and respiratory panel; YTD organic sales up 7.3% to €2,992m, driven by key product lines and regions.
Spotfire installations expanded by over 900 in Q3, with the install base up 160% YoY to 5,500; Spotfire sales more than doubled YTD (+114%).
BioFire non-respiratory panels grew 9% organically in Q3 and 10% YTD, with strong EMEA and Latin America performance.
Profitability remains solid over nine months, supported by GOSSIMPLE initiatives in automation, headcount, purchasing, and supply chain.
Q3 growth was impacted by declines in China and BioFire respiratory panels.
Financial highlights
Q3 organic sales growth was 3%, with reported sales down 2% due to a EUR 51 million negative FX impact; YTD consolidated sales were €2,992m, up 4.2% as reported and 7.3% organically.
Spotfire sales in Q3 were EUR 32 million (+66% organic), with a 2025 target of EUR 170 million.
BioFire respiratory panel sales declined 8% in Q3, but rose 6% organically over nine months.
Immunoassay sales declined, driven by a 17% drop in procalcitonin and continued weakness in China.
Currency effects negatively impacted sales by €85m over nine months, mainly due to euro appreciation.
Outlook and guidance
Full-year 2025 sales growth guidance revised to 5.5-6.5% at constant exchange rates, down from 6-7.5%.
Spotfire 2025 sales target revised to EUR 170 million (~90% organic growth), with 2028 target of EUR 450 million reaffirmed.
CBIT/CEBIT growth guidance for 2025 confirmed at 12-18% at constant exchange rates, with a -€30m currency effect expected.
Tariffs expected to have a EUR 35 million gross impact in 2026, with EUR 5-10 million net impact in 2025; mitigation actions underway.
China VBP impact on future sales?
SPOTFIRE® installed base growth drivers?
CEBIT growth despite lower sales guidance?
China market pressure duration?
Key drivers for confirmed CEBIT despite lower sales?
Path to GO•28 for Micro and Immuno?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next bioMérieux earnings date
Q4 20254 Mar, 2026
Next bioMérieux earnings date
Q4 20254 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
bioMérieux S.A. is a global biotechnology company that specializes in the development, manufacturing, and marketing of in vitro diagnostic solutions for medical and industrial applications. The company’s products include diagnostic tools for infectious diseases, oncology, cardiovascular diseases, and food safety testing. bioMérieux offers a range of systems, reagents, and software designed for microbiology, immunoassays, and molecular biology, helping healthcare providers and laboratories detect pathogens and analyze biological samples. The company also serves industrial markets, providing solutions for food safety, pharmaceutical quality control, and environmental monitoring. The company is headquartered in Marcy-l'Étoile, France, and its shares are listed on Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage